JRCT ID: jRCT2080225250
Registered date:29/06/2020
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 17/07/2020 |
Target sample size | 6000 |
Countries of recruitment | Asia except Japan,Japan,North America,South America,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | efficacy safety other |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 45age old |
Gender | Male |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT04199689,JapicCTI-205346 |
Contact
Public contact | |
Name | |
Address | |
Telephone | |
JPCT@merck.com | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | |
JPCT@merck.com | |
Affiliation |